Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01239732
Title A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

ovary epithelial cancer

peritoneal carcinoma

fallopian tube carcinoma

Therapies

Bevacizumab + Carboplatin + Paclitaxel

Age Groups: adult
Covered Countries ITA | FRA | ESP | CAN | AUT


No variant requirements are available.